Market Closed -
Other stock markets
|
After market 06:07:21 pm | |||
160.4 USD | -1.29% | 161.4 | +0.62% |
May. 08 | AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine | MT |
May. 08 | Daiwa Securities Adjusts Price Target on AbbVie to $171 From $190 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.54% | 287B | |
+32.95% | 700B | |
-4.97% | 358B | |
+18.83% | 330B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B | |
-1.81% | 157B | |
+3.70% | 124B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- UBS Adjusts AbbVie Price Target to $165 From $150, Maintains Neutral Rating